Comparative therapeutic efficiency of remdesivir in COVID in a tertiary care center by Mahendra Munirathnam, R Kishore, S N Sanjana, R Archita, C N Mohan, Preethi Rajeshwari Gandhi, Manjushree Mohan, Bhahuddin Mulla

Subjects: Get full text

Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven by Richard D. Shih, Dennis G. Maki, Charles H. Hennekens

Subjects: “…Remdesivir…”
Get full text

The use of Remdesivir in pregnant women with COVID-19 by Gulbanu Shaimerdenova, Gulzhan Abuova, Gaziza Yelshibek, Aisholpan Zhuparbek, Gulzhanat Bakytzhan, Samal Ashtayeva, Laura Sarypbekova

Subjects: Get full text

Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report by José A Gonzales-Zamora, Tanya Quiroz, Ana D. Vega

Subjects: Get full text

Remdesivir prescription in pregnant women infected with COVID-19: A report of compassionate use by Azam Zafarbakhsh, Atefeh Vaezi, Shaghayegh Haghjooy Javanmard, Fahimeh Sabet, Maryam Dehghan

Subjects: Get full text

Use of Remdesivir in children with COVID-19: report of an Italian multicenter study by Lorenza Romani, Marco Roversi, Stefania Bernardi, Elisabetta Venturini, Silvia Garazzino, Daniele Donà, Andrzej Krzysztofiak, Carlotta Montagnani, Elisa Funiciello, Francesca Ippolita Calò Carducci, Caterina Marabotto, Elio Castagnola, Filippo Salvini, Laura Lancella, Andrea Lo Vecchio, Luisa Galli, Guido Castelli Gattinara, Italian Society of Pediatric Infectious Diseases (SITIP)

Subjects: Get full text

Publicaciones sobre hidroxicloroquina y remdesivir: actualización septiembre 2020 by Flor álvarez de Toledo

Subjects: Get full text

Prominent bradycardia in a COVID-19 patient receiving Remdesivir: a case report by Sidhi Laksono Purwowiyoto, Grace Trifena Hosea

Subjects: “…remdesivir, bradycardia, covid-19…”
Get full text

Adverse effects of remdesivir for the treatment of acute COVID-19 in the pediatric population: a retrospective observational study by Abigail Schulz, Natalie Huynh, Margaret Heger, Mustafa Bakir

Subjects: “…Remdesivir…”
Get full text

Publicaciones sobre hidroxicloroquina y remdesivir: actualización septiembre 2020 by Flor álvarez de Toledo

Subjects: Get full text

Remdesivir versus standard-of-care for severe Coronavirus disease 2019 Infection: an analysis of 28-day mortality by Olender, Susan A., Walunas, Theresa L., Martinez, Esteban, Perez, Katherine K., Castagna, Antonella, Wang, Su, Kurbegov, Dax, Goyal, Parag, Ripamonti, Diego, Balani, Bindu, De Rosa, Francesco G., De Wit, Stéphane, Kim, Shin-Woo, Diaz, George, Bruno, Raffaele, Mullane, Kathleen M., Lye, David C., Gottlieb, Robert L., Haubrich, Richard H., Chokkalingam, Anand P., Wu, George, Diaz-Cuervo, Helena, Brainard, Diana M., Lee, I-Heng, Hu, Hao, Lin, Lanjia, Osinusi, Anu O., Bernardino, Jose I., Boffito, Marta

Subjects: Get full text

Recent knowledge in favor of remdesivir (GS-5734) as a therapeutic option for the COVID-19 infections by S. Saqrane, M.A. El Mhammedi, S. Lahrich, F. Laghrib, Y. El Bouabi, A. Farahi, M. Bakasse

Subjects: Get full text

Mortality in SARS-CoV-2 Hospitalized Patients Treated with Remdesivir: A Nationwide, Registry-Based Study in Italy by Pierluigi Russo, Evelina Tacconelli, Pier Paolo Olimpieri, Simone Celant, Antonietta Colatrella, Luca Tomassini, Giorgio Palù

Subjects: “…remdesivir…”
Get full text

The Effectiveness of the Use of Regdanvimab (CT-P59) in Addition to Remdesivir in Patients with Severe COVID-19: A Single Center Retrospective Study by Ganghee Chae, Aram Choi, Soyeoun Lim, Sooneun Park, Seungjun Lee, Youngick Ahn, Jinhyoung Kim, Seungwon Ra, Yangjin Jegal, Jongjoon Ahn, Eunji Park, Jaebum Jun, Woonjung Kwon, Taehoon Lee

Subjects: Get full text

Clinical outcomes of using remdesivir in patients with moderate to severe COVID-19: A prospective randomised study by Lakshmi Mahajan, A P Singh, Gifty

Subjects: Get full text

Remdesivir administration for SARS-CoV-2 pneumonia in ICU and non-ICU patients: outcome and posttreatment differences — the Italian Military Hospital experience by Antonio Sabba, Giancarlo Pontoni, Maria Santangelo, Nadir Rachedi, Maurizio D’Ercole, Bernardino Marseglia, Marcella Fusaro, Elena Giovanna Bignami, Costantino Fontana

Subjects: Get full text

Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models by Mohamed S. Imam, Ahmed H. Abdelazim, Sherif Ramzy, Afnan S. Batubara, Mohammed Gamal, Safwan Abdelhafiz, Abdallah M. Zeid

Subjects: Get full text

COVID‐19 treatment: A potential cause of acute pancreatitis by Magdy Mohamed Allam, Hanaa Tarek El‐Zawawy, Soha Magdy Ahmed, Mohamed Aly Abdelhamid

Subjects: Get full text

Does IHU-Méditerranée Infection influence Gilead Sciences' stock price? by E. Chabrière

Subjects: Get full text

Mucocutaneous adverse effects of remdesivir and favipiravir in patients with Covid-19 infection: A systematic review by Pradeep Balasubramanian, Chhakchhuak Laldinthari, Robert Lalnunpuia

Subjects: Get full text